Multiple myeloma is one of the most commonly diagnosed blood cancers. Due to introduction new therapies in recent years, there has been significant progress treating myeloma. Even so, with groups drugs, have some adverse events. In addition anti-myeloma treatment, patients require supportive therapies. This article presents principles treatment emergencies and discusses toxicity associated use ...